2022
DOI: 10.1007/s00134-021-06608-7
|View full text |Cite
|
Sign up to set email alerts
|

Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 49 publications
1
11
0
Order By: Relevance
“…Although the benefits and risks of adrenaline during cardiac arrests have been explored in large studies (2), post-ROSC adrenaline is an area of limited research. The optimal drug for post-resuscitation shock lacks high quality evidence (10). Variance in doses needs to be explored to ensure therapeutic doses are given and do not cause harm to patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the benefits and risks of adrenaline during cardiac arrests have been explored in large studies (2), post-ROSC adrenaline is an area of limited research. The optimal drug for post-resuscitation shock lacks high quality evidence (10). Variance in doses needs to be explored to ensure therapeutic doses are given and do not cause harm to patients.…”
Section: Discussionmentioning
confidence: 99%
“…The majority of research is undertaken in intensive care units or emergency departments (7,8,9,10). However, many patients where ROSC is achieved on-scene, re-arrest and die before entering trials for this literature.…”
Section: Introductionmentioning
confidence: 99%
“…Bougouin et al 3 conducted an observational cohort study comparing all-cause hospital mortality between patients treated with norepinephrine and epinephrine. The study used registry data comprising all out-of-hospital cardiac arrests presenting to five university hospitals in Paris with post-resuscitation shock, defined as a need for vasopressors for more than 6 hours post-ROSC despite adequate fluid loading.…”
Section: Epinephrine Vs Norepinephrine In Cardiac Arrest Patients Wit...mentioning
confidence: 99%
“…[4][5][6] Increasing MAP by administering low doses of vasopressors is possible after CA; noradrenaline is the usual first-line vasopressor. [7][8]9 Vasopressors may have adverse effects, including cardiac arrhythmias and increased myocardial oxygen consumption that can result in ischaemia and afterload elevation. 10 Severe side effects include re-arrest and/or the use of mechanical circulatory support.…”
Section: Introductionmentioning
confidence: 99%
“…Pilot studies have suggested alleviation of brain injury by targeting a higher mean arterial pressure after CA 4–6 . Increasing MAP by administering low doses of vasopressors is possible after CA; noradrenaline is the usual first‐line vasopressor 7–8,9 . Vasopressors may have adverse effects, including cardiac arrhythmias and increased myocardial oxygen consumption that can result in ischaemia and afterload elevation 10 .…”
Section: Introductionmentioning
confidence: 99%